These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 18677113

  • 21. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99.
    Lee XA, Verma C, Sim AYL.
    Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639
    [Abstract] [Full Text] [Related]

  • 22. MDMX: from bench to bedside.
    Marine JC, Dyer MA, Jochemsen AG.
    J Cell Sci; 2007 Feb 01; 120(Pt 3):371-8. PubMed ID: 17251377
    [Abstract] [Full Text] [Related]

  • 23. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.
    Sharp DA, Kratowicz SA, Sank MJ, George DL.
    J Biol Chem; 1999 Dec 31; 274(53):38189-96. PubMed ID: 10608892
    [Abstract] [Full Text] [Related]

  • 24. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation.
    Jackson MW, Lindstrom MS, Berberich SJ.
    J Biol Chem; 2001 Jul 06; 276(27):25336-41. PubMed ID: 11297540
    [Abstract] [Full Text] [Related]

  • 25. MDM2 interacts with MDMX through their RING finger domains.
    Tanimura S, Ohtsuka S, Mitsui K, Shirouzu K, Yoshimura A, Ohtsubo M.
    FEBS Lett; 1999 Mar 19; 447(1):5-9. PubMed ID: 10218570
    [Abstract] [Full Text] [Related]

  • 26. The MDMX acidic domain competes with the p53 transactivation domain for MDM2 N-terminal domain binding.
    Song Q, Liu XQ, Rainey JK.
    Biochim Biophys Acta Mol Cell Res; 2022 Oct 19; 1869(10):119319. PubMed ID: 35780910
    [Abstract] [Full Text] [Related]

  • 27. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oordt W, Hateboer G, van der Eb AJ, Jochemsen AG.
    EMBO J; 1996 Oct 01; 15(19):5349-57. PubMed ID: 8895579
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.
    Li C, Pazgier M, Li C, Yuan W, Liu M, Wei G, Lu WY, Lu W.
    J Mol Biol; 2010 Apr 30; 398(2):200-13. PubMed ID: 20226197
    [Abstract] [Full Text] [Related]

  • 36. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation.
    Xia M, Knezevic D, Tovar C, Huang B, Heimbrook DC, Vassilev LT.
    Cell Cycle; 2008 Jun 01; 7(11):1604-12. PubMed ID: 18520179
    [Abstract] [Full Text] [Related]

  • 37. MdmX inhibits Smad transactivation.
    Kadakia M, Brown TL, McGorry MM, Berberich SJ.
    Oncogene; 2002 Dec 12; 21(57):8776-85. PubMed ID: 12483531
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.